Cure8 research brief
The work links a missing bacterial metabolite (HDCA) to macrophage metabolism and reduced intestinal inflammation in experimental models, highlighting a potential microbiome-derived pathway that could be targeted for ulcerative colitis.
Researchers in microbiome and immunometabolism, translational IBD scientists, clinicians following emerging therapies, and patients interested in microbiome-related research.
The researchers found lower HDCA in UC and linked changes in a bacterial species (Ruminococcus callidus) to altered HDCA production. Single-cell RNA sequencing showed that HDCA shifts macrophage populations toward a metabolically reprogrammed, immunosuppressive phenotype.
Mechanistic work in mice and cells suggests HDCA acts through PPARγ-driven fatty acid metabolism and downstream epigenetic changes; the anti-inflammatory effect required myeloid PPARγ in mice. These results come from laboratory and mouse experiments and include single-cell and mechanistic molecular data.
The paper suggests HDCA or pathways it engages could be a potential therapeutic avenue, but this is preclinical and not an established treatment.
Preclinical mechanistic study using human samples for metabolite association plus mouse and cellular models. Findings are promising for target discovery but not yet applicable as clinical treatment.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of interests The authors declare no competing interests.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
The study identifies a gut bacteria–liver signaling axis (Lactobacillus johnsonii → hepatic LXRα–SCD1) that may explain how altered hepatic lipids contribute to UC and related liver injury, and shows pristimerin can...
The study identifies a fungal β-glucan that reduced inflammation and altered the gut microbiome and short-chain fatty acids in a mouse model of ulcerative colitis, which could inform future nutritional or therapeutic...
